• 1
    Kondo, M., Wagers, A. J., Manz, M. G., Prohaska, S. S., Scherer, D. C., Beilhack, G. F., Shizuru, J. A. et al., Biology of hematopoietic stem cells and progenitors: implications for clinical application. Annu. Rev. Immunol. 2003. 21: 759806.
  • 2
    Mantovani, A., Cassatella, M. A., Costantini, C. and Jaillon, S., Neutrophils in the activation and regulation of innate and adaptive immunity. Nat. Rev. Immunol. 2011. 11: 519531.
  • 3
    Pelletier, M., Maggi, L., Micheletti, A., Lazzeri, E., Tamassia, N., Costantini, C., Cosmi, L. et al., Evidence for a cross-talk between human neutrophils and Th17 cells. Blood 2010. 115: 335343.
  • 4
    Gabrilovich, D. I. and Nagaraj, S., Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 2009. 9: 162174.
  • 5
    Ostrand-Rosenberg, S. and Sinha, P., Myeloid-derived suppressor cells: linking inflammation and cancer. J. Immunol. 2009. 182: 44994506.
  • 6
    Collazo, M. M., Paraiso, K. H. T., Park, M.-Y., Hazen, A. and Kerr, W. G., Lineage extrinsic and intrinsic control of immunoregulatory cell numbers by SHIP. Eur. J. Immunol. 2012. 42: 17851796.
  • 7
    Koyasu, S., The role of PI3K in immune cells. Nat. Immunol. 2003. 4: 313319.
  • 8
    Sly, L. M., Rauh, M. J., Kalesnikoff, J., Buchse, T. and Krystal, G., SHIP, SHIP2, and PTEN activities are regulated in vivo by modulation of their protein levels: SHIP is up-regulated in macrophages and mast cells by lipopolysaccharide. Exp. Hematol. 2003. 31: 11701181.
  • 9
    Helgason, C. D., Damen, J. E., Rosten, P., Grewal, R., Sorensen, P., Chappel, S. M., Borowski, A. et al., Targeted disruption of SHIP leads to hemopoietic perturbations, lung pathology, and a shortened life span. Genes Dev. 1998. 12: 16101620.
  • 10
    Lee, D. W., Futami, M., Carroll, M., Feng, Y., Wang, Z., Fernandez, M., Whichard, Z. et al., Loss of SHIP-1 protein expression in high-risk myelodysplastic syndromes is associated with miR-210 and miR-155. Oncogene 2012. doi: 10.1002/eji.2361/pdf
  • 11
    Ooms, L. M., Horan, K. A., Rahman, P., Seaton, G., Gurung, R., Kethesparan, D. S. and Mitchell, C. A., The role of the inositol polyphosphate 5-phosphatases in cellular function and human disease. Biochem. J. 2009. 419: 2949.
  • 12
    Hazen, A. L., Smith, M. J., Desponts, C., Winter, O., Moser, K. and Kerr, W. G., SHIP is required for a functional hematopoietic stem cell niche. Blood 2009. 113: 29242933.
  • 13
    Sampson, M., Zhu, Q. S. and Corey, S. J., Src kinases in G-CSF receptor signaling. Front Biosci. 2007. 12: 14631474.
  • 14
    O'Connell, R. M., Chaudhuri, A. A., Rao, D. S. and Baltimore, D., Inositol phosphatase SHIP1 is a primary target of miR-155. Proc. Natl. Acad. Sci. U. S. A. 2009. 106: 71137118.
  • 15
    Ruschmann, J., Ho, V., Antignano, F., Kuroda, E., Lam, V., Ibaraki, M., Snyder, K. et al., Tyrosine phosphorylation of SHIP promotes its proteasomal degradation. Exp. Hematol. 2010. 38: 392402, 402 e391.
  • 16
    Lechner, M. G., Liebertz, D. J. and Epstein, A. L., Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells. J. Immunol. 2010. 185: 22732284.
  • 17
    Serafini, P., Mgebroff, S., Noonan, K. and Borrello, I., Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells. Cancer Res. 2008. 68: 54395449.
  • 18
    Kashiwada, M., Cattoretti, G., McKeag, L., Rouse, T., Showalter, B. M., Al-Alem, U., Niki, M. et al., Downstream of tyrosine kinases-1 and Src homology 2-containing inositol 5'-phosphatase are required for regulation of CD4+CD25+ T cell development. J. Immunol. 2006. 176: 39583965.
  • 19
    Locke, N. R., Patterson, S. J., Hamilton, M. J., Sly, L. M., Krystal, G. and Levings, M. K., SHIP regulates the reciprocal development of T regulatory and Th17 cells. J. Immunol. 2009. 183: 975983.
  • 20
    Horwitz, D. A., Identity of mysterious CD4+CD25-Foxp3+ cells in SLE. Arthritis Res. Ther. 2010. 12: 101.
  • 21
    Tarasenko, T., Kole, H. K., Chi, A. W., Mentink-Kane, M. M., Wynn, T. A. and Bolland, S., T cell-specific deletion of the inositol phosphatase SHIP reveals its role in regulating Th1/Th2 and cytotoxic responses. Proc. Natl. Acad. Sci. U. S. A. 2007. 104: 1138211387.
  • 22
    Turka, L. A. and Walsh, P. T., IL-2 signaling and CD4+CD25+Foxp3+ regulatory T cells. Front Biosci. 2008. 13: 14401446.
  • 23
    Hagenbeek, T. J., Naspetti, M., Malergue, F., Garcon, F., Nunes, J. A., Cleutjens, K. B., Trapman, J. et al., The loss of PTEN allows TCR alphabeta lineage thymocytes to bypass IL-7 and Pre-TCR-mediated signaling. J. Exp. Med. 2004. 200: 883894.
  • 24
    Gardai, S., Whitlock, B. B., Helgason, C., Ambruso, D., Fadok, V., Bratton, D. and Henson, P. M., Activation of SHIP by NADPH oxidase-stimulated Lyn leads to enhanced apoptosis in neutrophils. J. Biol. Chem. 2002. 277: 52365246.
  • 25
    Mondal, S., Subramanian, K. K., Sakai, J., Bajrami, B. and Luo, H. R., Phosphoinositide lipid phosphatase SHIP1 and PTEN coordinate to regulate cell migration and adhesion. Mol. Biol. Cell 2012. 23: 12191230.
  • 26
    Ong, C. J., Ming-Lum, A., Nodwell, M., Ghanipour, A., Yang, L., Williams, D. E., Kim, J. et al., Small-molecule agonists of SHIP1 inhibit the phosphoinositide 3-kinase pathway in hematopoietic cells. Blood 2007. 110: 19421949.
  • 27
    Brooks, R., Fuhler, G. M., Iyer, S., Smith, M. J., Park, M. Y., Paraiso, K. H., Engelman, R. W. et al., SHIP1 inhibition increases immunoregulatory capacity and triggers apoptosis of hematopoietic cancer cells. J. Immunol. 2010. 184: 35823589.
  • 28
    Fuhler, G. M., Brooks, R., Toms, B., Iyer, S., Gengo, E. A., Park, M. Y., Gumbleton, M. et al., Therapeutic potential of SH2 domain-containing inositol-5'-phosphatase 1 (SHIP1) and SHIP2 inhibition in cancer. Mol. Med. 2012. 18: 6575.